3Wang P,Hu F,Xiong Z,et al.SusceptibiIity of ESBL-producing Enterobacteriaceae according to the new CLSI breakpoints[J].J Clin Microbiol,2011,49(9):3127-3131.
4Zaniani FR,Meshkat Z,Naderi Nasab M,et al.The prevalence of TEM and SHV genes among extended-spectrum beta-lactamases producing Escherichia coli and Klebsiella pneumoniae[J].Iran J Basic Med Sci,2012,15(1):654-660.
5Iarrili R,Giannouli M,Tomasone F,et al.Cabapenem resistance in Acinetobatet baumannii:the molecular epidemic features of an emerging problem in health care facilities[J].J Infect Dev Ctries,2009,3(5):335-341.
6Weinstein MP, Towns ML, Quartey SM, et al.The clinical siginificance of positive blood cultures in the 1990s:a prospective comprehensive evaluation of the microbiology , epidemiology, and outcome of bacteremia and fungem in adults [J] .Clin Infect Dis, 1997,24(4) : 584-602.
7Bourneton O,Mutel T,Heranney D,et al.Incidence of hospital acquired and community acquired bloodstream infections in the university of strasbourg Hospital, France, between 2005 and 2007 [J] .Pathol Biol (Paris), 2010,58 ( 1 ) : 29-34.
8Morris JD,Hewitt JL,Wolfe LG,et al.Imaging and analysis of seudomnas aeruginosa swarming and rhamnolipd [J].Appl Environ Microbiol. 2011.77 ( 23 ) : 8310-8317.
